Search results
Results from the WOW.Com Content Network
Silk Road Medical (SILK) delivered earnings and revenue surprises of -29.03% and -5.09%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Silk Road Medical ( NASDAQ:SILK ) Third Quarter 2022 Results Key Financial Results Revenue: US$37.4m (up 51% from 3Q...
Silk Road Medical (SILK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Silk Road Medical (SILK) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further ...
(Reuters) -Boston Scientific will buy Silk Road Medical in a $1.16 billion deal, the company said on Tuesday, adding medical devices used for stroke prevention. Boston, which generates most of its ...
Silk Road Medical (SILK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
For premium support please call: 800-290-4726 more ways to reach us
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission states that Erica Rogers exercised options to purchase 15,738 Silk Road Medical shares at prices ranging from $1.46 ...